SLC5A2 and type 2 diabetes mellitus: Peters et al. [8] also analyzed 13 episodes of SGLT-2 inhibitor-associated euglycemic DKA or ketosis in 9 individuals, seven with type 1 diabetes and two with type 2 diabetes.